Which statement accurately contrasts thiazide diuretics with loop diuretics in hypertension management?

• A. Thiazides inhibit the Na–Cl cotransporter in the distal convoluted tubule, producing milder diuresis with risk of hyponatremia and hypokalemia; commonly used for essential hypertension and mild edema.
• B. Thiazides inhibit NKCC in the thick ascending limb; potent diuresis; risk hypokalemia and hypomagnesemia; used for edema from heart failure.
• C. Loop diuretics inhibit Na–Cl cotransporter in distal tubule; mild diuresis.
• D. Loop diuretics block ENaC in collecting duct; mild diuresis.

Answer: (A)

Distinguishing where these diuretics act and how that affects their strength and typical use in hypertension.

Thiazide diuretics block the Na-Cl cotransporter in the distal convoluted tubule, which reduces sodium reabsorption modestly and produces milder diuresis. This milder effect is advantageous for long-term blood pressure control and makes them a common first-line choice for essential hypertension and for mild edema. The diuretic action comes with electrolyte shifts, notably hyponatremia and hypokalemia, which aligns with their clinical profile.

In contrast, loop diuretics inhibit the NKCC transporter in the thick ascending limb and cause much more potent diuresis with greater losses of potassium and magnesium; they’re typically reserved for edema from heart failure, nephrotic syndrome, or other volume-overload states, rather than as a primary treatment for essential hypertension.

So the statement that correctly contrasts them captures the distal-tubule action of thiazides, the milder diuresis, the risk of hyponatremia and hypokalemia, and their use in essential hypertension and mild edema.